Sustained release of heme–albumin as a potential novel therapeutic approach for age-related macular degeneration

Megan Allyn, María A. Rincon‐Benavides, Heather L. Chandler, Natalia Higuita‐Castro, Andre F. Palmer, Katelyn E. Swindle‐Reilly

Biomaterials Science · 2022 · 16 citations · 16 references

Concepts

Abstract

ROS-responsive polydopamine nanoparticles sustain release of heme–albumin, increasing HO-1 expression in retinal cells, demonstrating a potential therapeutic approach for treatment of inflammatory conditions such as age-related macular degeneration.

References

16